MS
Mandeep Singh Kalra
About Mandeep Singh Kalra
Mandeep Singh Kalra has 5 years in corporate governance. Holds Additional Director and Director roles. Currently with 3 companies, including Systole Remedies Private Limited and Flanca Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Systole Remedies Private Limited
U24230DL2005PTC191854
|
Additional Director | 13 Jul 2021 | 2005 | Active |
Flanca Life Sciences Private Limited
U51909CH2022PTC044768
|
Director | 30 Dec 2022 | 2022 | Active |
|
Iris Prints Private Limited
U82920HP2025PTC012113
|
Director | 27 Oct 2025 | 2025 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandeep Singh Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandeep Singh Kalra
Mandeep Singh Kalra has 5 years in corporate governance. Holds Additional Director and Director roles. Currently with 3 companies, including Systole Remedies Private Limited and Flanca Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Mandeep Singh Kalra is associated with 3 companies as Additional Director and Director.
Mandeep Singh Kalra has expertise in General Business.
Mandeep Singh Kalra has 5 years in corporate governance.